All News Huaren Pharmaceutical Co., Ltd.

Equities

300110

CNE100000SW1

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-20 pm EDT			5-day change	1st Jan Change
3.53 ^CNY	-1.94%		-5.11%	-16.35%

Apr. 24	Huaren Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 24	Huaren Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Huaren Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2023	Apr. 24	CI
Huaren Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 24	CI
Huaren Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 24	CI
Huaren Pharmaceutical Co., Ltd. cancelled the transaction announced on March 23, 2023	Apr. 22	CI
Huaren Pharma's Unit Gets Nod for Medical Device	Apr. 04	MT
Huaren Pharma's Unit Gets Nod to Add Specifications to Antibiotic Product	Feb. 22	MT
Huaren Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-24	CI
Huaren Pharmaceutical Co., Ltd.(XSEC:300110) added to S&P Global BMI Index	23-09-18	CI
Huaren Pharmaceutical Co., Ltd. Announces Director Appointments	23-09-13	CI
Huaren Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-25	CI
Huaren Pharmaceutical Co., Ltd. Approves Final Cash Dividend for the Year 2022, Payable on 12 July 2023	23-07-03	CI
Huaren Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-19	CI
Huaren Pharmaceutical Co., Ltd. Proposes Final Dividend for 2022	23-03-27	CI
Huaren Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-24	CI
Huaren Pharmaceutical Co., Ltd. announced that it expects to receive CNY 1.339851 billion in funding from Xi'an Qujiang Tianshou Great Health Investment Partnership Enterprise ( Limited Partnership)	23-03-22	CI
Huaren Pharma Appoints Executive President	22-12-30	MT
Huaren Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-20	CI
Huaren Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-19	CI
Huaren Pharmaceutical Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on June 17, 2022	22-06-13	CI
Huaren Pharmaceutical Co., Ltd. Approves Board Appointments	22-04-22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Huaren Pharmaceutical Co., Ltd.

Equities

300110

CNE100000SW1

All News

Filters